Gene · 4214
Papers4,517
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,517
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognosis stratification and response to treatment in breast cancer based on one-carbon metabolism-related signature. | Front Oncol | 2023 | 38239641 | PubTator, text mining | PubMed |
| NR5A1-related 46,XY partial gonadal dysgenesis: A case report and literature review. | Medicine (Baltimore) | 2023 | 38206718 | PubTator, text mining | PubMed |
| Recent trends in insect gut immunity. | Front Immunol | 2023 | 38193088 | PubTator, text mining | PubMed |
| A model for predicting clinical prognosis based on brain metastasis-related genes in patients with breast cancer. | Transl Cancer Res | 2023 | 38192988 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Review of two immunosuppressants: tacrolimus and cyclosporine. | J Korean Assoc Oral Maxillofac Surg | 2023 | 38155084 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority. | Front Immunol | 2023 | 38152394 | PubTator, text mining | PubMed |
| Paeoniflorin Induces ER Stress-Mediated Apoptotic Cell Death by Generating Nox4-Derived ROS under Radiation in Gastric Cancer. | Nutrients | 2023 | 38140352 | PubTator, text mining | PubMed |
| Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries. | Int J Mol Sci | 2023 | 38139236 | PubTator, text mining | PubMed |
| Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods. | Life (Basel) | 2023 | 38137905 | PubTator, text mining | PubMed |
| The Role of Mesenchymal Stem Cells in Modulating the Breast Cancer Microenvironment. | Cell Transplant | 2023 | 38135917 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities. | Cell Discov | 2023 | 38114467 | PubTator, text mining | PubMed |
| Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones. | Chin Med | 2023 | 38111074 | PubTator, text mining | PubMed |
| Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. | Mol Cancer | 2023 | 38111008 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Constructing a T-Cell Receptor-Related Gene Signature for Prognostic Stratification and Therapeutic Guidance in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38067199 | PubTator, text mining | PubMed |
| Flower color polymorphism of a wild Iris on the Qinghai-Tibet plateau. | BMC Plant Biol | 2023 | 38066415 | PubTator, text mining | PubMed |
| MaxCLK: discovery of cancer driver genes via maximal clique and information entropy of modules. | Bioinformatics | 2023 | 38065693 | PubTator, text mining | PubMed |
| [Mutation pedigree and treatment selection of Erdheim-Chester disease]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049347 | PubTator, text mining | PubMed |
| Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis. | Orphanet J Rare Dis | 2023 | 38037140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4214/papers?page=9